On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini. This instrumentation change is necessary as Bio-Rad is discontinuing service on our existing QuickStep instrumentation.
Although the Immucor assay and sample requirements will remain the same, the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list will be available on the CTS website on 04/29/19.
On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the changes to F...
Celebrate National Blood Donor Month throughout January by inviting eligible individuals to donate b...
That’s just one of the reasons that National Blood Donor Month, which has taken place each Jan...
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...